跳至主要内容
临床试验/CTRI/2025/04/084348
CTRI/2025/04/084348尚未招募2/3 期

A RANDOMIZED CONTROLLED OPEN LABELLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PALASHWALKA KWATHA WITH SHARKARA IN THE MANAGEMENT OF RAKTAPRADAR WITH SPECIAL REFERANCE TO MENORRHAGIA

Dr Komal Santosh Kasliwal1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月16日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To study the efficacy of Palashwalka kwatha with Sharkara

研究概览

简要总结

This Study is Randomised controlled clinical study to evaluate the efficacy of Palashwalka Kwatha with Sharkara in the management of raktapradar. Oral administration of Palashwalka kwatha with Sharkara 40ml Twicea day before meal from 2nd day of menstruation for 7day Follow up on 9th day of menses  for 3 consecutive menstrual cycle effect in Raktapradar (Menorrhagia).this study will be carried out in 2 years of PG course.

研究设计

研究类型
Interventional
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Diagnosed cases of Raktapradar.
  • Age – 20 to 40 year married and unmarried female.
  • Patient with every socioeconomical status.

排除标准

  • Patient having genital malignancy.
  • Patient having IUCD.
  • Patient having Uterine fibroid and other pelvic pathologies .
  • Patient suffering from severe anemia , STD.
  • Patient suffering from Acute medical condition and other systemic disorders for example Hypertension,Coagulation disorder.
  • Patient having history of currently taking OC PILLS, Harmonal therapies .

结局指标

主要结局

To study the efficacy of Palashwalka kwatha with Sharkara

时间窗: 7 Day

次要结局

  • No Any(No)

研究者

发起方
Dr Komal Santosh Kasliwal
申办方类型
Other [(self)]

研究点 (1)

Loading locations...

相似试验